NSE: MARKSANS

Marksans Pharma Ltd Share Price

Company information and financial fundamentals for Marksans Pharma Ltd, alongside its latest NSE share price.

Last price₹313.40+2.69% today · prev close ₹305.20
SectorHealthcare

About Marksans Pharma Ltd

Marksans Pharma is engaged in the Business of Formulation of pharmaceutical products [1]

Classification: Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals · NSE symbol: MARKSANS

Company fundamentals

Market Cap₹ 14,213 Cr.
Current Price₹ 314
High / Low₹ 351 / 155
Stock P/E27.5
Book Value₹ 66.7
Dividend Yield0.29 %
ROCE18.8 %
ROE15.2 %
Face Value₹ 1.00

Figures are as reported by the company and compiled by screener.in (fetched 2026-11-03); they may lag the latest filing. Educational information, not investment advice.

Quarterly results (₹ crore)

Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales560591642682708620720754856841
Expenses450462495543582520576594661628
Operating Profit110128147139127100144161195213
OPM %20%22%23%20%18%16%20%21%23%25%
Other Income1715-02815622203525
Interest5333366667
Depreciation21202021232327242425
Profit before tax10012012514311677133151200207
Tax %23%26%22%27%22%24%26%25%25%23%
Net Profit788998105915899114149159
EPS in Rs1.731.962.132.312.001.292.172.503.273.47
Raw PDF——————————

Profit and loss, yearly (₹ crore)

Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales9131,0001,1341,3761,4911,8522,1772,6232,9513,172
Expenses8348689421,0371,2321,5131,7192,0902,3502,458
Operating Profit78132192340259340459533601714
OPM %9%13%17%25%17%18%21%20%20%22%
Other Income85074259506682102
Interest1010988911122425
Depreciation272327364552748399100
Profit before tax50104157302248338424504561691
Tax %28%23%23%21%25%21%26%24%25%—
Net Profit3680121239187265315383420521
EPS in Rs0.801.872.955.764.515.886.928.409.2211.41
Dividend Payout %6%3%3%4%6%9%9%10%10%—

Compounded growth

Compounded Sales Growth10 Years 13%5 Years 16%3 Years 17%TTM 20%
Compounded Profit Growth10 Years 18%5 Years 12%3 Years 16%TTM 48%
Stock Price CAGR10 Years 21%5 Years 36%3 Years 41%1 Year 64%
Return on Equity10 Years 17%5 Years 17%3 Years 16%Last Year 15%

Balance sheet (₹ crore)

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital41414141414145454545
Reserves3924305025958461,1611,7002,0202,4222,978
Borrowings1101181003034111123244322343
Other Liabilities209142160236307323322372451489
Total Liabilities7527318029021,2281,6362,1902,6813,2403,856
Fixed Assets2672792703033094284867769821,044
CWIP00001231092759
Investments00000012710
Other Assets4844515335999071,2051,6941,8692,2302,753
Total Assets7527318029021,2281,6362,1902,6813,2403,856

Cash flows (₹ crore)

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity14502723317999237230207458
Cash from Investing Activity-21-39-13-60-45-84-259-141-49-249
Cash from Financing Activity-33-21-114-1580198-69-65-71
Net Cash Flow-1015-760118941762193138
Free Cash Flow-141114174133531842235329
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit31%73%41%134%67%66%88%77%62%99%

Efficiency ratios

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days118716478729782767580
Inventory Days151152215155248216192217270278
Days Payable12954787110310291949896
Cash Conversion Cycle140169202163217211183199247261
Working Capital Days77709787104121122129142149
ROCE %4%10%18%25%38%23%22%21%20%19%

Shareholding pattern (%)

Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Promoters43.87%43.87%43.87%43.87%43.87%43.87%43.87%43.87%43.87%43.87%
FIIs18.59%21.31%21.95%22.19%19.89%16.92%8.13%16.76%17.47%19.06%
DIIs3.75%4.10%4.30%4.55%5.50%5.28%5.91%6.57%6.19%5.54%
Public33.77%30.70%29.88%29.37%30.74%33.93%42.08%32.78%32.46%31.53%
No. of Shareholders2,35,5002,48,8452,59,8132,57,2732,56,2212,65,7882,55,1532,46,2792,46,6352,47,508

Exchange disclosures

Next results date

Marksans Pharma Ltd has a board meeting for financial results listed on 2026-11-04. Companies can reschedule; check the company's own announcement. Results calendar

Shown as filed with NSE. A filing shows that something happened, not why, and says nothing about what to do.

Compare MARKSANS with APOLLOHOSP →

Wondering what to do with Marksans Pharma Ltd?

This page shares company information and reported fundamentals. It does not tell you whether to buy, hold or sell. For a view that takes your own holding and goal into account, ask Samjho Bhai, our portfolio review tool.

Ask Samjho Bhai about MARKSANS →

How this page works · New to company fundamentals? Start learning.

Key terms: Nifty 50 · Price-to-earnings ratio · Earnings per share · Dividend yield · Market capitalisation

Other Healthcare stocks in the NSE

Apollo HospitalsNSE: APOLLOHOSPCiplaNSE: CIPLADr. Reddy's LaboratoriesNSE: DRREDDYMax HealthcareNSE: MAXHEALTHSun PharmaNSE: SUNPHARMA

Frequently asked questions

What is the NSE symbol for Marksans Pharma Ltd?

Marksans Pharma Ltd trades on the NSE under the symbol MARKSANS.

Where is Marksans Pharma Ltd listed?

Marksans Pharma Ltd is listed on the National Stock Exchange of India (NSE) under the symbol MARKSANS. It is not part of the NIFTY 50 or NIFTY 500 lists this site tracks.

Should I buy Marksans Pharma Ltd shares?

Market Dekho does not give buy, sell or hold recommendations and is not a SEBI-registered Research Analyst or Investment Adviser. To review a holding against your own goal and risk, you can use Samjho Bhai, or speak to a SEBI-registered adviser.

Prices are delayed and sourced from a public market-data provider; they may contain errors. This page is educational information, not investment advice.